跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30,218 条关于
“ALK-EML4 positive NSCLC”
全部
30,218
临床试验
18,761
药物
633
机构
86
资讯
10,738
11个月前
Genprex's Reqorsa Gene Therapy Shows 79% Tumor Reduction in ALK-Positive Lung Cancer Preclinical Study
去年
Genprex and University of Michigan Partner to Study Reqorsa® Gene Therapy in ALK+ Lung Cancer
去年
Lorlatinib Shows Impressive 5-Year PFS Results in ALK-Positive Advanced NSCLC
去年
ALNEO Trial Demonstrates Promising Perioperative Alectinib Activity in Stage III ALK-Positive NSCLC
去年
Alectinib Plus Bevacizumab Shows Promising Results in First-Line Treatment of ALK-Positive NSCLC
去年
Adjuvant Crizotinib Fails to Improve Disease-Free Survival in Early-Stage ALK-Positive NSCLC
8年前
Genetic Variants and Their Impact on Clinical Responses to Treatments
5个月前
Xuanzhu Biopharma's DiLuoAke Demonstrates Superior Efficacy Over Crizotinib in Phase III ALK-Positive NSCLC Trial
4个月前
Xcovery Partners with EVERSANA to Expand Commercial Launch of ALK-Positive NSCLC Drug Ensacove
去年
Ongoing Trials Explore Novel Combinations and Adjuvant Therapies in EGFR- and ALK-Mutant NSCLC
第 1 页,共 1074 页
上一页
下一页